Browsing Category
Pharma Industry News
4741 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Why Bristol Myers Squibb is walking away from its first China joint venture after four decades
Bristol Myers Squibb’s 60% stake sale in its China JV shows a pivot from generics to innovation. Find out what this means for its stock and growth outlook.
Why GSK is investing $30bn in the U.S. now—and what it means for global pharma manufacturing
GSK to invest $30B in U.S. R&D and manufacturing amid trade policy shifts—find out how this shapes global pharma supply chains and investor sentiment.
Eisai’s etalanetug earns FDA Fast Track status, signaling new hope in Alzheimer’s therapy
Eisai’s etalanetug gets FDA Fast Track for Alzheimer’s, signaling a major shift toward tau-targeting therapies. Find out what this means for investors.
What makes gene-editing tools like CRISPR 3.0 the next frontier in precision medicine?
Delve into the next generation of gene-editing tools, such as prime editing, and see how they may revolutionize precision medicine – read more now!
Novo Nordisk eyes FDA approval for high-dose 7.2mg Wegovy after STEP UP trial shows 21% weight loss
Novo Nordisk seeks U.S. approval for 7.2mg Wegovy after 21% average weight loss in trials. Can it outpace Eli Lilly’s Zepbound in the obesity drug race?
Bright Green merges with PharmAGRI, names Lynn Stockwell CEO, plans IPO and Tesla robot rollout to reboot U.S. drug supply
Bright Green merges with PharmAGRI, names Lynn Stockwell CEO, and plans IPO with Tesla robots to rebuild U.S. drug supply. Here’s why it matters now.
Why Henlius Biotech’s HLX43 deal talks with Johnson & Johnson and Roche are shaking up global oncology
Henlius Biotech is negotiating with Johnson & Johnson and Roche on HLX43 rights. Learn how this deal could reshape oncology licensing and investor sentiment.
Nyrada Inc (ASX: NYR) stock draws fresh attention as investors eye trial milestones in 2025
Nyrada Inc (ASX: NYR) stock is moving on higher volumes as trial milestones near. Find out why investors are watching this biotech in 2025.
Renvio partners with Klinrisk to embed predictive AI in dialysis care
Discover how Renvio and Klinrisk are embedding predictive AI into dialysis EMRs to transform kidney care and cut preventable hospitalizations.
Krystal Biotech stock jumps after FDA expands Vyjuvek label to newborns and at-home use
Krystal Biotech stock surged after the FDA expanded Vyjuvek’s label to newborns and caregiver use, boosting adoption potential and investor confidence.